Registration and Continental Breakfast—Exhibits Open, Grand Ballroom Prefunction
Welcome and Opening Remarks, Theresa Franco, RN, MSN, Executive Director, Cancer Care Service Line, The Nebraska Medical Center, and Mark Leenay, MD, Chief Medical Officer and Sr. Vice President, Optum Clinical Programs
Treatment Options for Pancreatic Adenocarcinoma, Aaron Sasson, MD, University of Nebraska Medical Center
The incidence of pancreatic cancer has markedly increased over the last several decades. Despite the progress in cancer treatment and increased survival overall, pancreatic cancer remains very difficult to treat. An average of only 5 percent of these patients are alive five years post-diagnosis. Dr. Sasson will discuss the role of a multidisciplinary team in creating the treatment plan for patients diagnosed with adenocarcinoma of the pancreas, and will highlight surgical advances used in treating these patients.
- Identify the factors used in the patient-selection process for pancreatic surgery.
- Discuss the role of multidisciplinary management of pancreatic adenocarcinoma.
- Recognize the different treatment options for pancreatic adenocarcinoma.
Genetics Counseling: Indications and Risk/Benefit Considerations, Gwen Reiser, MS, University of Nebraska Medical Center
Cancer genetics is the study of hereditary and familial cancer. The primary goal of cancer genetics counseling is to identify individuals and families at increased risk of cancer for the purpose of promoting awareness, early detection and cancer prevention. In this presentation, Ms. Reiser will discuss the indications for cancer genetics testing and the need for concurrent counseling. She will describe the role of the cancer genetics counselor in promoting patient and family understanding of the testing process, the test results, and the possible psychosocial impact of those results.
- Identify features of the disease and family history suggestive of a hereditary cancer.
- List the risks, benefits and limitations of genetics testing.
- Describe the role of the cancer genetics counselor.
Break—Exhibits Open, Grand Ballroom Prefunction
Blood and Marrow Stem Cell Transplantation: The Principles, the Process and When It Gets Personal, R. Gregory Bociek, MD, and Tawny Roeder, RN, MSN, University of Nebraska Medical Center; Debra Hendriks and Cory Roeder, Transplant Patient Family Caregivers
Blood and marrow stem cell transplantation is an important treatment option for an increasing number of malignant and nonmalignant disorders. Almost 15,000 of these transplants are performed in the United States each year.
In this session, Dr. Bociek will describe the therapeutic components of stem cell transplantation, including the various types of transplants, preparative regimens, potential toxicities and possible complications. In addition, the role of the transplant case manager in supporting and guiding the patient into and through the transplant process is outlined by Tawny Roeder. Ms. Roeder’s presentation highlights critical nursing care involved in side-effect management during the conditioning and recovery phases. A former patient and family caregivers will discuss their experiences during the transplant process and share some of their insights.
- List the rationale for the various types of hematopoietic stem cell transplants.
- Describe the various steps on the transplant timeline from initial consultation to recovery.
- Explore the experience of the patient and family caregivers on their survival journey through the transplant process.
Lunch (provided) Grand Ballroom North; Exhibits Open, Grand Ballroom Prefunction
Human Research: Internal Controls, Scientific Method and Nursing Implications, Apar Ganti, MD, MS; Bruce Gordon, MD, FAAP; and Maribeth Hohenstein, RN, University of Nebraska Medical Center
Without research, advances in cancer prevention, detection, diagnosis and treatment are compromised. However, research using human subjects must be both scientifically and ethically rigorous. The design of cancer clinical trials must carefully balance patient welfare, scientific design and regulatory constraints. Sponsors, investigators, research coordinators and institutional review boards (IRBs) must work together. Virtually every cancer treatment available today is the direct result of clinical research. Yet only about 4 percent of the 1.7 million people who will be diagnosed with cancer in the U.S. this year will participate in a clinical trial.
- Discuss the historical background of the establishment of institutional review boards in the U.S.
- Lists the benefits and potential risks of cancer clinical trials.
- Identify the phases of clinical trials.
- Describe the role of nursing in overcoming barriers and improving participation in clinical trials.
Break—Exhibits Open, Grand Ballroom Prefunction
Current Perspectives in the Management of Esophageal Cancer, Rudy Lackner, MD, University of Nebraska Medical Center
There were over 17,000 new cases of esophageal cancer diagnosed in 2012 and over 15,000 deaths associated with this disease. Prognosis and treatment options tend to be dependent on the stage of the disease at diagnosis and the overall health status of the patient. Unfortunately, most esophageal cancers are diagnosed as locoregionally advanced disease in patients over the age of 60, who often suffer from multiple comorbidities.
In this session, Dr. Lackner will discuss the multimodality treatment indicated for locoregionally advanced esophageal cancer and review the historical and current surgical treatment options.
- Discuss the history of esophageal surgery.
- Recognize the surgical options available for the treatment of esophageal cancer.
- State the outcomes of various treatment options for locoregionally advanced esophageal cancer.
The Role of Interventional Radiology in Delivering Locoregional Therapies for Hepatocellular Carcinoma, Joseph McBride, MD, University of Nebraska Medical Center
Over 18,000 people worldwide are diagnosed with liver cancer each year, with hepatocellular carcinoma (HCC) being the most common type. According to the National Comprehensive Cancer Network (NCCN) Guidelines, locoregional therapy should be considered in patients with HCC, who are not candidates for resection or transplantation. Highly qualified as vascular experts, interventional radiologists are uniquely skilled in using the vascular system to deliver targeted treatments to the liver. Dr. McBride will discuss the various ablative and embolization therapies currently used for locoregional treatment of HCC.
- Review the indications, contraindications, advantages and limitations of regional therapies in treating liver cancer.
- Describe interventional radiology technologies available for tumor ablation in treating liver cancer.
- State the interventional radiology technologies available for tumor embolization in treating liver cancer.
Radiotherapy-Related Breast Toxicity: A Review of Chronic Toxicities, Andrew Wahl, MD, University of Nebraska Medical Center
Radiation therapy plays an integral role in the treatment of breast cancer. However, radiotherapy is associated with several side effects that adversely affect the patient’s overall quality of life. When taking into account the long life expectancy of many of these breast cancer survivors, chronic-radiotherapy-related breast toxicities need to be considered.
Dr. Wahl will review the types and incidence of chronic toxicities experience by many patients receiving radiotherapy for breast cancer and discuss the impact on patients’ quality of life and overall survival. He will focus on innovative treatment-delivery methods that decrease late cardiovascular side effects of breast radiotherapy.
- List radiotherapy-related breast toxicities associated with negative cosmetic outcomes, including toxicities that cause functional impairment or chronic pain.
- Describe innovative treatment-delivery methods that minimize the life-threatening risk of cardiovascular side effects of breast radiotherapy.
- Indicate the need for long-term follow-up in patients who have chronic toxicities due to radiotherapy for breast cancer that may compromise their quality of life and overall survival.
Getting Acquainted Reception—Exhibits Open, Grand Ballroom Prefunction
Please join us for complimentary drinks and hors d’oeuvres. This unique evening will provide attendees the opportunity to get further acquainted with the services and staff within this comprehensive medical center.